These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1152 related articles for article (PubMed ID: 17496446)

  • 1. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
    Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
    Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term outcome of advanced hepatocellular carcinoma that received transarterial hepatic chemotherapy].
    Masutani S; Shimizu J; Tatsuta M; Masuda F; Imamura H; Ishida H; Furukawa H; Tomotsu K; Yura M; Obana T; Kitamura S; Saeki N; Inoue Y; Takamura M; Ohnishi H
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1579-82. PubMed ID: 14619468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein.
    Itamoto T; Nakahara H; Tashiro H; Haruta N; Asahara T; Naito A; Ito K
    J Surg Oncol; 2002 Jul; 80(3):143-8. PubMed ID: 12115797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study.
    Niguma T; Mimura T; Tutui N
    J Hepatobiliary Pancreat Surg; 2005; 12(3):249-53. PubMed ID: 15995815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
    Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M; Kobayashi Y; Urawa N; Yamamoto M; Mifuji R; Araki J; Tanaka H; Horiike S; Itani T; Furjita N; Konishi M; Iwasa M; Kaito M; Adachi Y
    Hepatogastroenterology; 2007 Mar; 54(74):518-21. PubMed ID: 17523311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC
    Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatic arterial infusion of low-dose cisplatin, 5-fluorouracil for hepatocellular carcinoma with tumor thrombi in the portal vein].
    Itamoto T; Asahara T; Kohashi T; Katayama S; Fukuda S; Nakatani T; Fukuda T; Yano M; Nakahara H; Katayama K; Haruta N; Dohi K
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1832-5. PubMed ID: 10560406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of hepatocellular carcinoma responding to hepatic arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil].
    Takeda Y; Hasuike Y; Tsujinaka T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1712-7. PubMed ID: 11708016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma].
    Osuga K; Murakami T; Nakata S; Tomoda K; Nagano H; Monden M; Nakamura H
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2114-7. PubMed ID: 15628754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of hepatocellular carcinoma with portal tumor thrombus effectively treated by arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil].
    Nakazaki H; Takita W; Watanabe M; Hasebe Y; Tokura N; Seo A; Kurihara A; Takada M; Saito N; Shirasaka K; Kobayashi K; Hirano K
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):599-602. PubMed ID: 11977546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
    Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K
    J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of repeated hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Sim MK; Kim DY; Park JY; Kim JK; Kim SA; Ahn SH; Chon CY; Moon YM; Won JY; Lee DY; Han KH
    Korean J Hepatol; 2005 Sep; 11(3):268-74. PubMed ID: 16177553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma.
    Murata K; Shiraki K; Kawakita T; Yamamoto N; Okano H; Nakamura M; Sakai T; Deguchi M; Ohmori S; Nakano T
    Anticancer Res; 2003; 23(2C):1719-22. PubMed ID: 12820447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The study of continuous local arterial-infusion chemotherapy with 5-FU + CDDP for patients with severely advanced HCC--for the elongation of the life-span and the improvement of QOL].
    Toyoda H; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Suga T; Oki H; Takahashi M
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1495-8. PubMed ID: 8396904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modified pharmacokinetic modulation chemotherapy (PMC) with medication of UFT and intraarterial infusion of 5-FU for advanced unresectable HCC].
    Kamiyama T; Matsushita M; Kurauchi N; Nakagawa T; Kamachi H; Kondo M; Ito T; Ogata T; Nishikawa M; Todo S
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2527-31. PubMed ID: 12506476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.